{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:39:39Z","timestamp":1787240379955,"version":"build-2736575974"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1213\/ane.0000000000000643","type":"journal-article","created":{"date-parts":[[2015,2,18]],"date-time":"2015-02-18T09:56:38Z","timestamp":1424253398000},"page":"1235-1241","source":"Crossref","is-referenced-by-count":23,"title":["Analysis of Remifentanil with Liquid Chromatography-Tandem Mass Spectrometry and an Extensive Stability Investigation in EDTA Whole Blood and Acidified EDTA Plasma"],"prefix":"10.1213","volume":"120","author":[{"given":"Remco A.","family":"Koster","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo E. M.","family":"Vereecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Greijdanus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daan J.","family":"Touw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel M. R. F.","family":"Struys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Willem C.","family":"Alffenaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-13-20210902","doi-asserted-by":"crossref","first-page":"80","DOI":"10.2165\/00003088-199529020-00003","article-title":"Remifentanil pharmacokinetics and pharmacodynamics. A preliminary appraisal.","volume":"29","author":"Egan","year":"1995","journal-title":"Clin Pharmacokinet"},{"key":"R2-13-20210902","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0090-9556(25)07242-3","article-title":"The pharmacokinetics and extra-hepatic clearance of remifentanil, a short acting opioid agonist, in male beagle dogs during constant rate infusions.","volume":"24","author":"Chism","year":"1996","journal-title":"Drug Metab Dispos"},{"key":"R3-13-20210902","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0731-7085(94)90035-3","article-title":"Determination of remifentanil in human and dog blood by HPLC with UV detection.","volume":"12","author":"Selinger","year":"1994","journal-title":"J Pharm Biomed Anal"},{"key":"R4-13-20210902","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S1570-0232(02)00524-X","article-title":"Simultaneous solid-phase extraction combined with liquid chromatography with ultraviolet absorbance detection for the determination of remifentanil and its metabolite in dog plasma.","volume":"783","author":"Kabbaj","year":"2003","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"R5-13-20210902","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0731-7085(99)00151-X","article-title":"Determination of remifentanil in human heparinised whole blood by tandem mass spectrometry with short-column separation.","volume":"21","author":"Bender","year":"1999","journal-title":"J Pharm Biomed Anal"},{"key":"R6-13-20210902","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jpba.2006.04.029","article-title":"LC-MS determination of remifentanil in maternal and neonatal plasma.","volume":"42","author":"Bossu","year":"2006","journal-title":"J Pharm Biomed Anal"},{"key":"R7-13-20210902","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/0731-7085(96)01831-6","article-title":"Determination of remifentanil, an ultra-short-acting opioid anesthetic, in rat blood by high performance liquid chromatography with ultraviolet detection.","volume":"14","author":"Haidar","year":"1996","journal-title":"J Pharm Biomed Anal"},{"key":"R8-13-20210902","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S1570-0232(02)00178-2","article-title":"Determination of remifentanil in human blood by capillary gas chromatography with nitrogen-selective detection.","volume":"775","author":"Bjorksten","year":"2002","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"R9-13-20210902","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.jchromb.2011.02.002","article-title":"Determination of remifentanil in human plasma by liquid chromatography-tandem mass spectrometry utilizing micro extraction in packed syringe (MEPS) as sample preparation.","volume":"879","author":"Said","year":"2011","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"R10-13-20210902","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.forsciint.2009.01.013","article-title":"Simultaneous screening and quantification of 25 opioid drugs in post-mortem blood and urine by liquid chromatography-tandem mass spectrometry.","volume":"186","author":"Gergov","year":"2009","journal-title":"Forensic Sci Int"},{"key":"R11-13-20210902","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0731-7085(94)90030-2","article-title":"Determination of remifentanil in human blood by liquid-liquid extraction and capillary GC-HRMS-SIM using a deuterated internal standard.","volume":"12","author":"Grosse","year":"1994","journal-title":"J Pharm Biomed Anal"},{"key":"R13-13-20210902","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1097\/00000539-200211000-00038","article-title":"In vitro remifentanil metabolism: the effects of whole blood constituents and plasma butyrylcholinesterase.","volume":"95","author":"Davis","year":"2002","journal-title":"Anesth Analg"},{"key":"R14-13-20210902","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/FTD.0b013e318192304c","article-title":"Robust, high-throughput LC-MSMS method for therapeutic drug monitoring of cyclosporine, tacrolimus, everolimus, and sirolimus in whole blood.","volume":"31","author":"Koster","year":"2009","journal-title":"Ther Drug Monit"},{"key":"R15-13-20210902","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2165\/11317690-000000000-00000","article-title":"Predictive performance of the Minto remifentanil pharmacokinetic parameter set in morbidly obese patients ensuing from a new method for calculating lean body mass.","volume":"49","author":"La Colla","year":"2010","journal-title":"Clin Pharmacokinet"},{"key":"R16-13-20210902","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/00000542-199701000-00004","article-title":"Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development.","volume":"86","author":"Minto","year":"1997","journal-title":"Anesthesiology"},{"key":"R17-13-20210902","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/00000542-199701000-00005","article-title":"Pharmacokinetics and pharmacodynamics of remifentanil. II. Model application.","volume":"86","author":"Minto","year":"1997","journal-title":"Anesthesiology"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000000643","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:24:12Z","timestamp":1786112652000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000539-201506000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0000000000000643","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]}}}